Please wait while the formulary information is being retrieved.
VALIUM (DIAZEPAM)
- Alcohol withdrawal syndrome
- Anxiety
- Muscle spasm
- Alcohol withdrawal delirium
- Sedation
10 mg tablet
- 1 tablet (10 mg) by oral route 3 times per day
2 mg tablet
- 1 tablet (2 mg) by oral route 3 times per day
5 mg tablet
- 1 tablet (5 mg) by oral route 2 times per day
10 mg tablet
- 1 tablet (10 mg) by oral route 3 times per day
2 mg tablet
- 1 tablet (2 mg) by oral route 3 times per day
5 mg tablet
- 1 tablet (5 mg) by oral route 2 times per day
Alcohol withdrawal delirium
- 1 tablet (5 mg) by oral route 3 times per day as needed
- 1 tablet (5 mg) by oral route 4 times per day as needed
Anxiety
- 1 tablet (2 mg) by oral route 2 times per day
- 1 tablet (2 mg) by oral route 3 times per day
- 1 tablet (2 mg) by oral route 4 times per day
- 2 tablets (4 mg) by oral route 3 times per day
- 2 tablets (4 mg) by oral route 4 times per day
- 2 tablets (4 mg) by oral route 2 times per day
- 1 tablet (5 mg) by oral route 4 times per day
- 1 tablet (5 mg) by oral route 3 times per day
- 1 tablet (5 mg) by oral route 2 times per day
- 2 tablets (10 mg) by oral route 2 times per day
- 2 tablets (10 mg) by oral route 3 times per day
- 1 tablet (10 mg) by oral route 2 times per day
- 1 tablet (10 mg) by oral route 3 times per day
- 1 tablet (10 mg) by oral route 4 times per day
- 2 tablets (10 mg) by oral route 4 times per day
Muscle spasm
- 1 tablet (2 mg) by oral route 2 times per day
- 1 tablet (2 mg) by oral route 3 times per day
- 1 tablet (2 mg) by oral route 4 times per day
- 2 tablets (4 mg) by oral route 3 times per day
- 2 tablets (4 mg) by oral route 4 times per day
- 2 tablets (4 mg) by oral route 2 times per day
- 1 tablet (5 mg) by oral route 4 times per day
- 1 tablet (5 mg) by oral route 3 times per day
- 1 tablet (5 mg) by oral route 2 times per day
- 2 tablets (10 mg) by oral route 2 times per day
- 2 tablets (10 mg) by oral route 3 times per day
- 1 tablet (10 mg) by oral route 2 times per day
- 1 tablet (10 mg) by oral route 3 times per day
- 1 tablet (10 mg) by oral route 4 times per day
- 2 tablets (10 mg) by oral route 4 times per day
- sodium oxybate
- Xyrem
Contraindicated
- clozapine
- Clozaril
- Dehydrated Alcohol
- ethanol (ethyl alcohol)
- ethyl alcohol-herbal drugs
- Fazaclo
- fluoxetine
- fluvoxamine
- Luvox Cr
- Lydia Pinkham Herbal
- nefazodone
- olanzapine-fluoxetine
- Prozac
- Prozac Weekly
- Sarafem
- Symbyax
- Versacloz
Severe
Moderate
- Acid Reducer (cimetidine)
- Acid Relief (cimetidine)
- buprenorphine-naloxone
- cimetidine
- Diflucan
- fluconazole
- fluconazole in dextrose(iso-o)
- fluconazole in NaCl (iso-osm)
- Heartburn Relief
- isoniazid-rifamp-pyrazinamide
- itraconazole
- ketoconazole
- Noxafil
- Onmel
- posaconazole
- Rifadin
- Rifamate
- rifampin
- rifampin-isoniazid
- Rifater
- Sporanox
- Sporanox Pulsepak
- Suboxone
- Tagamet Hb
- Vfend
- Vfend Iv
- voriconazole
- Zubsolv
- Lactating mother
- Myasthenia gravis
- Pregnancy
- Severe hepatic disease
- Sleep apnea
Contraindicated
- Alcohol intoxication
- Angle-closure glaucoma
- Depression
- Respiratory depression
- Severe chronic obstructive pulmonary disease
Severe
Moderate
- CYp2c19 poor metabolizer
- Disease of liver
- Drug abuse
- Hypoalbuminemia
- Open angle glaucoma
- Pulmonary disease
- Severe renal impairment
VALIUM (DIAZEPAM)
- Alcohol withdrawal syndrome
- Anxiety
- Muscle spasm
- Alcohol withdrawal delirium
- Sedation
- Muscle weakness
- Ataxia
- Dizziness
- Drowsy
- Dyspepsia
- Slurred speech
More Frequent
Severe
Less Severe
- Acute confusion
- Behavioral disorders
- CNS depression
- Diarrhea
- Fatigue
- General weakness
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Abnormal hepatic function tests
- Accidental fall
- Agranulocytosis
- Anaphylaxis
- Anemia
- Angioedema
- Aplastic anemia
- Apnea
- Coma
- Dehydration
- Depression
- Disease of liver
- Drug-induced psychosis
- Eosinophilia
- Hallucinations
- Hemolytic anemia
- Hepatomegaly
- Hostility
- Hypotension
- Jaundice
- Leukocytosis
- Leukopenia
- Manic disorder
- Memory impairment
- Neutropenic disorder
- Respiratory depression
- Seizure disorder
- Skin rash
- Sleep walking disorder
- Suicidal ideation
- Thrombocytopenic disorder
- Urinary retention
Less Severe
- Aggressive behavior
- Agitation
- Alopecia
- Anorexia
- Aphonia
- Blurred vision
- Bronchial congestion
- Complex sleep behavior
- Concentration difficulty
- Conjunctivitis
- Constipation
- Contact dermatitis
- Cramps
- Delirium
- Depersonalization
- Diplopia
- Disturbance in thinking
- Dream disorder
- Drug dependence
- Dry eye
- Dry skin
- Dysarthria
- Dyspnea
- Dysuria
- Excitement
- Eyes vertical deviation
- Facial edema
- Gastritis
- Gingival pain
- Glossitis
- Headache disorder
- Hiccups
- Hirsutism
- Increased appetite
- Irritability
- Libido changes
- Loss of taste
- Lymphadenopathy
- Menstrual disorder
- Myalgias
- Nausea
- Nervousness
- Nightmares
- Nocturia
- Nystagmus
- Orthostatic hypotension
- Palpitations
- Paranoid disorder
- Polydipsia
- Pruritus of skin
- Rhinorrhea
- Sialorrhea
- Sleep disorder
- Sneezing
- Sore tongue
- Stomatitis
- Swelling of ankles or feet
- Syncope
- Tachycardia
- Tremor
- Urinary incontinence
- Urine discoloration
- Vertigo
- Visual changes
- Visual field defect
- Vomiting
- Weight gain
- Weight loss
- Xerostomia
- Yawning
Contraindicated
Diazepam (Oral)
Not recommended in children under 6 months due to insufficient safety information.
- 1 Day – 179 Days
- 1 Not recommended in children under 6 months due to insufficient safety information.
Severe Precaution
None
Management or Monitoring Precaution
None
Diazepam (oral)
- Severity Level:
1
- Additional Notes: Risk of malformations if used in 1st trim; withdrawal sx if used in 3rd trim
Contraindicated
Diazepam
Not recommended: infant sedation, lethargy, feeding difficulty.
| General | Excretion Potential | Effect on Infant | Notes |
| Drug should not be given to breast feeding mothers | Excreted | Drug shown to have adverse effect | Not recommended: infant sedation, lethargy, feeding difficulty. |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Diazepam
General-Inc risk of adverse psychiatric and paradoxical reaction. Limit to short term use. Limit use of other CNS active meds that inc fall risk including opioids. May be appropriate for some indications including seizure disorder and severe generalized anxiety disorder. Neuro/Psych-Inc risk of cognitive impair, delirium, falls, fractures, and motor vehicle crashes. Renal-Active metab are renally excreted. Use caution in renal impair. Start with 2-2.5 mg/day and titrate as tolerated.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- Taking diazepam with opioid medications (such as codeine, hydrocodone) may increase your risk of very serious side effects, including death. To lower your risk, your doctor should have you take the smallest dose of diazepam that works, and take it for the shortest possible time. Get medical help right away if any of these very serious side effects occur: slow/shallow breathing, unusual lightheadedness, severe drowsiness/dizziness, difficulty waking up.
| Alcohol withdrawal delirium | |
| F10.231 | Alcohol dependence with withdrawal delirium |
| Alcohol withdrawal syndrome | |
| F10.23 | Alcohol dependence with withdrawal |
| F10.230 | Alcohol dependence with withdrawal, uncomplicated |
| F10.231 | Alcohol dependence with withdrawal delirium |
| F10.232 | Alcohol dependence with withdrawal with perceptual disturbance |
| F10.239 | Alcohol dependence with withdrawal, unspecified |
| Anxiety | |
| F06.4 | Anxiety disorder due to known physiological condition |
| F10.180 | Alcohol abuse with alcohol-induced anxiety disorder |
| F10.280 | Alcohol dependence with alcohol-induced anxiety disorder |
| F10.980 | Alcohol use, unspecified with alcohol-induced anxiety disorder |
| F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
| F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
| F12.980 | Cannabis use, unspecified with anxiety disorder |
| F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
| F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
| F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
| F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
| F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
| F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
| F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
| F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
| F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
| F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
| F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
| F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
| F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
| F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
| F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
| F40 | Phobic anxiety disorders |
| F40.0 | Agoraphobia |
| F40.00 | Agoraphobia, unspecified |
| F40.01 | Agoraphobia with panic disorder |
| F40.02 | Agoraphobia without panic disorder |
| F40.1 | Social phobias |
| F40.10 | Social phobia, unspecified |
| F40.11 | Social phobia, generalized |
| F40.8 | Other phobic anxiety disorders |
| F40.9 | Phobic anxiety disorder, unspecified |
| F41 | Other anxiety disorders |
| F41.0 | Panic disorder [episodic paroxysmal anxiety] |
| F41.1 | Generalized anxiety disorder |
| F41.3 | Other mixed anxiety disorders |
| F41.8 | Other specified anxiety disorders |
| F41.9 | Anxiety disorder, unspecified |
| F93.0 | Separation anxiety disorder of childhood |
| Muscle spasm | |
| M62.83 | Muscle spasm |
| M62.830 | Muscle spasm of back |
| M62.831 | Muscle spasm of calf |
| M62.838 | Other muscle spasm |
| R25.2 | Cramp and spasm |
| 0-9 | A-Z |
|---|---|
| F06.4 | Anxiety disorder due to known physiological condition |
| F10.180 | Alcohol abuse with alcohol-induced anxiety disorder |
| F10.23 | Alcohol dependence with withdrawal |
| F10.230 | Alcohol dependence with withdrawal, uncomplicated |
| F10.231 | Alcohol dependence with withdrawal delirium |
| F10.231 | Alcohol dependence with withdrawal delirium |
| F10.232 | Alcohol dependence with withdrawal with perceptual disturbance |
| F10.239 | Alcohol dependence with withdrawal, unspecified |
| F10.280 | Alcohol dependence with alcohol-induced anxiety disorder |
| F10.980 | Alcohol use, unspecified with alcohol-induced anxiety disorder |
| F12.180 | Cannabis abuse with cannabis-induced anxiety disorder |
| F12.280 | Cannabis dependence with cannabis-induced anxiety disorder |
| F12.980 | Cannabis use, unspecified with anxiety disorder |
| F14.180 | Cocaine abuse with cocaine-induced anxiety disorder |
| F14.280 | Cocaine dependence with cocaine-induced anxiety disorder |
| F14.980 | Cocaine use, unspecified with cocaine-induced anxiety disorder |
| F15.180 | Other stimulant abuse with stimulant-induced anxiety disorder |
| F15.280 | Other stimulant dependence with stimulant-induced anxiety disorder |
| F15.980 | Other stimulant use, unspecified with stimulant-induced anxiety disorder |
| F16.180 | Hallucinogen abuse with hallucinogen-induced anxiety disorder |
| F16.280 | Hallucinogen dependence with hallucinogen-induced anxiety disorder |
| F16.980 | Hallucinogen use, unspecified with hallucinogen-induced anxiety disorder |
| F18.180 | Inhalant abuse with inhalant-induced anxiety disorder |
| F18.280 | Inhalant dependence with inhalant-induced anxiety disorder |
| F18.980 | Inhalant use, unspecified with inhalant-induced anxiety disorder |
| F19.180 | Other psychoactive substance abuse with psychoactive substance-induced anxiety disorder |
| F19.280 | Other psychoactive substance dependence with psychoactive substance-induced anxiety disorder |
| F19.980 | Other psychoactive substance use, unspecified with psychoactive substance-induced anxiety disorder |
| F40 | Phobic anxiety disorders |
| F40.0 | Agoraphobia |
| F40.00 | Agoraphobia, unspecified |
| F40.01 | Agoraphobia with panic disorder |
| F40.02 | Agoraphobia without panic disorder |
| F40.1 | Social phobias |
| F40.10 | Social phobia, unspecified |
| F40.11 | Social phobia, generalized |
| F40.8 | Other phobic anxiety disorders |
| F40.9 | Phobic anxiety disorder, unspecified |
| F41 | Other anxiety disorders |
| F41.0 | Panic disorder [episodic paroxysmal anxiety] |
| F41.1 | Generalized anxiety disorder |
| F41.3 | Other mixed anxiety disorders |
| F41.8 | Other specified anxiety disorders |
| F41.9 | Anxiety disorder, unspecified |
| F93.0 | Separation anxiety disorder of childhood |
| M62.83 | Muscle spasm |
| M62.830 | Muscle spasm of back |
| M62.831 | Muscle spasm of calf |
| M62.838 | Other muscle spasm |
| R25.2 | Cramp and spasm |
Formulary Reference Tool